Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) EBT Margin (2020 - 2025)

Celularity (CELU) has disclosed EBT Margin for 6 consecutive years, with 436.71% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin fell 26354.0% to 436.71% in Q3 2025 year-over-year; TTM through Sep 2025 was 348.61%, a 27591.0% decrease, with the full-year FY2024 number at 106.77%, up 75522.0% from a year prior.
  • EBT Margin was 436.71% for Q3 2025 at Celularity, down from 427.55% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 1267.03% in Q2 2022 to a low of 3065.38% in Q1 2021.
  • A 5-year average of 672.89% and a median of 173.17% in 2024 define the central range for EBT Margin.
  • Biggest YoY gain for EBT Margin was 651608bps in 2021; the steepest drop was -608935bps in 2021.
  • Celularity's EBT Margin stood at 82.78% in 2021, then skyrocketed by 815bps to 592.08% in 2022, then crashed by -87bps to 78.91% in 2023, then crashed by -2549bps to 1932.12% in 2024, then surged by 77bps to 436.71% in 2025.
  • Per Business Quant, the three most recent readings for CELU's EBT Margin are 436.71% (Q3 2025), 427.55% (Q2 2025), and 172.89% (Q1 2025).